Prothena Corporation plc growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: -58.0%
EBITDA: +44.0%
EBIT: +8.9%
EPS: -36.4%
Free cash flow: +37.6%
Operating cash flow: +37.6%

Forward estimates

Revenue: +10.1%
EBITDA: +37.9%
EPS: +94.2%

Three-year CAGR

Revenue: -43.6%
EBITDA: -54.0%
EBIT: -19.4%
Net income: -99.6%
EPS: -99.6%
Free cash flow: -8.9%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.